What is the current price of ROIX?

The current price of ROIX is $0.00. Prices are updated in real time on Stocks360.

What is ROIX's market capitalization?

ROIX's market capitalization is $12.00, placing it in the small-cap tier.

Response Oncology, Inc. (ROIX)

Stock analysis · OTC · Healthcare · Medical - Care Facilities

$0.00

Market Cap

$12.00

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

-19.14

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

500.00

Response Oncology, Inc. (ROIX) is a Stock listed on the OTC exchange in the Healthcare sector, specifically in the Medical - Care Facilities industry. The company has a market capitalization of $12. Historically, Response Oncology, Inc. operated as a comprehensive cancer management firm, but it has largely ceased its business activities. With a recent price of $0.00, the company's current state is a far cry from its past operations. To learn more about ROIX, explore the data and analysis below.

Response Oncology, Inc. (ROIX) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $12.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Response Oncology, Inc.

Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its operating assets, with the expectation that all remaining assets would be sold and wind-down procedures finalized by the end of that year. Historically, the company functioned as a comprehensive cancer management firm, providing advanced cancer treatment through its outpatient IMPACT Centers, overseeing the non-medical aspects of oncology practices, compounding and dispensing pharmaceuticals to specific oncologists, and conducting outcomes research for pharmaceutical manufacturers.